CEVA Animal Health has introduced Marbokem to its comprehensive range of injectable anti-infectives – a Marbofloxacin-based antimicrobial for the treatment of respiratory disease in cattle.
CEVA Animal Health has introduced Marbokem to its comprehensive range of injectable anti-infectives – an “efficient and cost-effective” Marbofloxacin-based antimicrobial for the treatment of respiratory disease in cattle and offers the advantages of a one-shot protocol and a shock-resistant vial.
According to the company, Marbokem is used for the treatment of respiratory infections caused by sensitive strains of Pasteurella multocida, Mannheimia haemolytica and Histophilus somni.
Marbofloxacin’s efficacy has been proven in terms of re-treatment rate, success, speed of action and MICs in comparison with many frequently used quinolones and macrolides.
Marbokem’s one shot protocol means it is quick and economical to use, while its presentation in an ergonomic CLAS vial makes for light and shock-resistant handling, resulting in fewer breakages and reduced costs. Marbokem is also said to be very competitively priced.
CEVA has years of experience and undeniable expertise in manufacturing anti-infectives and Marbokem complements the company’s popular bovine range, which includes Cevaxel and Florkem. For further product information contact CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG, telephone 01494 781510 or visit www.ceva.uk.com